Skip to main content
SpringerLink
Log in

Atheromatous Embolism

  • Chapter
Peripheral Arterial Disease

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 194 Accesses

Abstract

Atheromatous embolization is due to the travel of atheromatous debris from large arteries to wedge into the microcirculation of body parts or organs. It may present as a blue toe syndrome or as malignant embolization to body organs such as the kidneys and brain. The most common cause is manipulation of a severely athermatous aorta or artery by catheterization or surgery. Treatment modalities of atheroemblism are inadequate, and many patients continue to suffer excess morbidity and even mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hollier LH, Kazmier FJ, Ochsner J, Bowen JC, Procter CD. “Shaggy” aorta syndrome with atheromatous embolization to visceral vessels. Ann Vasc Surg 1991, 5: 439–444.

    Article  PubMed  CAS  Google Scholar 

  2. Kumpe DA Zwerdlinger S, Griffin DJ. Blue toe syndrome: treatment with percutaneous transluminal angioplasty. Radiology 1988; 166: 37–44.

    PubMed  CAS  Google Scholar 

  3. Brewer ML, Kinnison ML, Perler BA, White RI Jr. Blue toe syndrome: treatment with anticoagulants and delayed percutaneous transluminal angioplasty. Radiology 1988; 166: 31–36.

    PubMed  CAS  Google Scholar 

  4. Moolenaar W, Lamers CBHW. Cholesterol crystal embolization in the Netherlands. Arch Int Med 1996; 156: 653–657.

    Article  CAS  Google Scholar 

  5. Maurizi CP, Barker AE, Trueheart RE. Atheromatous emboli. Arch Pathol 1968; 86: 528–534.

    PubMed  CAS  Google Scholar 

  6. Kealy WF. Atheroembolism. J Clin Pathol 1978; 31: 984–989.

    Article  PubMed  CAS  Google Scholar 

  7. Eliot RS, Kanjuh VI, Edwards JE. Atheromatous embolism. Circulation 1964; 30: 611–618.

    Article  PubMed  CAS  Google Scholar 

  8. Colt HG, Begg RJ, Saporito JJ, Cooper WM, Shapiro AP. Cholesterol emboli after cardiac catheterization. Medicine 1988; 67: 389–400.

    Article  PubMed  CAS  Google Scholar 

  9. Blankenship JC, Butler M, Garbes A. Prospective assessment of cholesterol embolization in patients with acute myocardial infarction treated with thrombolytic vs. conservative therapy. Chest 1995; 107: 662–668.

    Article  PubMed  CAS  Google Scholar 

  10. Hyman BT, Landas SK, Ashman RF, Schelper RL, Robinson RA. Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med 1987; 82: 1233–1237.

    Article  PubMed  CAS  Google Scholar 

  11. Davis K, Kennedy JW, Kemp HG Jr., Judkins M, Gosselin AJ, Killip T. Complications of coronary arteriography from the collaborative study of coronary artery surgery (CASS). Circulation 1979; 59: 1105–1112.

    Article  PubMed  CAS  Google Scholar 

  12. Gafter U, Chagnac A, Levi J. Cholesterol emboli in atherosclerotic patients: reports of four cases occurring spontaneously or complicating angioplasty and aortorenal bypass. J Am Geriat Soc 1987; 35: 357–359.

    PubMed  Google Scholar 

  13. Schwartz MW, McDonald GB. Cholesterol embolization syndrome. JAMA 1987; 258: 1934–1935

    Google Scholar 

  14. Ben-Chitrit S, Korzets R, Hershovitz R, Bernheim J, Schneider M. Cholesterol embolization following thrombolytic therapy with streptokinase and tissue plasminogen activator. Nephrol Dial Transplant 1994; 9: 428–430.

    PubMed  CAS  Google Scholar 

  15. Feder W, Auerbach R. “Purple toes”: an uncommon sequela of oral coumarin drug therapy. Ann Intern Med 1961; 55: 911–917.

    PubMed  CAS  Google Scholar 

  16. Anderson WR, Richards AM. Evaluation of lower extremity muscle biopsies in the diagnosis or atheroembolism. Arch Pathol 1968; 86: 535–541.

    PubMed  CAS  Google Scholar 

  17. Leroy D, Michel M, Mandard J, Elie H, Deschamps P. Association of disseminated intravascular coagulation and cutaneous crystal emboli. Ann Dermatol Venereal 1981; 108: 665–673.

    CAS  Google Scholar 

  18. Harvey JC. Cholesterol microembolization: a cause of restless leg syndrome. South Med J 1976; 69: 269–272.

    Article  PubMed  CAS  Google Scholar 

  19. Haywood TA, Fessel WJ, Strange DA. Atheromatous microembolism simulating polymyositis. JAMA 1968; 203: 135–137.

    Google Scholar 

  20. Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol 1986; 122: 1194–1198.

    Article  PubMed  CAS  Google Scholar 

  21. Comerford JA, Broe PJ, Wilson IA, Bourchier-Hayes DJ. Digital ischaemia and palpable pedal pulses. Br J Surg 1987; 74: 93–95.

    Article  Google Scholar 

  22. Kasinath BS, Corwin HL, Bidani AK, Korbet SM, Swartz MM, Lewis EJ. Eosinophilia in the diagnosis of atheroembolic renal disease. Am J Nephrol 1987; 7: 173–177.

    Article  PubMed  CAS  Google Scholar 

  23. Wilson DM, Salazer TL, Farkouh ME.Eosinophiluria in atheroembolic renal disease. Am J Med 1991; 91: 186–189.

    Article  PubMed  CAS  Google Scholar 

  24. Cosio FG, Zager RA, Sharma HM. Atheroembolic renal disease causes hypocomplementemia. Lancet 1985; 2: 118–121.

    Article  PubMed  CAS  Google Scholar 

  25. Ferrari E, Taillan B, Drai E, Morand P Baudouy M. Investigation of the transthoracic aorta in cholesterol embolization by transesophageal echocardiography. Heart1998; 79: 133–136

    Google Scholar 

  26. Deschamps P, LeRoy D, Mandard JC, Heron JF, Lawret P. Livedo reticularis and nodules due to cholesterol embolism in the lower extremities. Br J Dermatol 1977; 97: 93–97.

    Article  PubMed  CAS  Google Scholar 

  27. Kvilekval K, Yunis JR Mason RA, Giron E After the blue toe: prognosis of non-cardiac arterial embolization in the lower extremities. J Vasc Surg 1993; 17: 328–335.

    CAS  Google Scholar 

  28. Morris-Jones W, Preston FE, Greeney M, Chatterjee DK. Gangrene of the toes with palpable pulses: response to platelet suppressive therapy. Ann Surg 1981; 193: 462–466.

    Article  PubMed  CAS  Google Scholar 

  29. Benvegna S, Cassina I, Giuntini G, Rusignuolo F, Talarico F, Florena M. Atherothrombotic microembolism of the lower extremities (the blue toe syndrome) from atherosclerotic nonaneurysmal aortic plaques. J Cardiovasc Surg 1990; 31: 87–91.

    CAS  Google Scholar 

  30. Coffman JD. Clinical forum: atheroembolism after cardiac surgery. J Vasc Med Biol 1989; 1: 37–41.

    Google Scholar 

  31. Belenfant X, D’Auzac C, Bariéty J, Jacquot C. Embolies de cristaux de cholesterol au cours de traitements par héparine de bas poids moléculaire. Presse Med 1997; 26: 1236–1237.

    PubMed  CAS  Google Scholar 

  32. Vacher-Coponat H, Pache X, Dussol B, Bertrand Y. Pulmonary-renal syndrome responding to corticosteroids: Consider cholesterol embolization. Nephrol Dial Transplant 1997; 12: 1977–1979.

    Article  CAS  Google Scholar 

  33. Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis 1999; 33: 840–845

    Article  PubMed  CAS  Google Scholar 

  34. Fabbian F, Catalano C, Lambertini D, Bordin V, DiLandro D. A possible role of corticosteroids in cholesterol crystal embolization. Nephron 1999; 83: 189–190.

    Article  PubMed  CAS  Google Scholar 

  35. Stabellini N, Rizzioli E, Trapassi MR, Fabbian F, Catalano C, Gillis P. Renal cholesterol microembolization: is steroid therapy effective? Nephron 2000: 86: 239–240.

    Article  PubMed  CAS  Google Scholar 

  36. Graziani G, Stanostasi S, Angelini C, Badalamenti S. Corticosteroids in cholesterol emboli syndrome. Nephron 2001; 87: 371–373.

    Article  PubMed  CAS  Google Scholar 

  37. Woolfson RG, Lachmann H. Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet 1998; 351: 1331–1332.

    Article  PubMed  CAS  Google Scholar 

  38. Finch TM, Ryatt KS. Livedo reticularis caused by cholesterol embolization may improve with simvastatin. Br J Dermat 2000; 143: 1319–1320.

    Article  CAS  Google Scholar 

  39. Rumpf KW, Schult S, Mueller GA. Simvastatin treatment in cholesterol emboli syndrome. Lancet 1998; 352: 321–322.

    Article  PubMed  CAS  Google Scholar 

  40. Cabali S, Hochman I Goor Y. Reversal of gangrenous lesions in the blue toe syndrome with lovastatin: a case report. Angiology 1993; 44: 821–825.

    Article  Google Scholar 

  41. Tsunoda S, Daimon S, Miyazaki R, Fujii H, Imazu A, Mabarchi. LDL apheresis as intensive lipid-lowering therapy for cholesterol embolization. Nephrol Dial Transplant 1999; 14: 1041–1042.

    Article  PubMed  CAS  Google Scholar 

  42. Carr ME Jr, Sanders K, Todd WM. Pain relief and clinical improvement temporally related to the use of pentoxifylline in a patient with documented cholesterol emboli—a case report. Angiology 1994; 45: 65–69.

    Article  PubMed  Google Scholar 

  43. Ferrari E, Vidal R, Chevalier T, Baudony M. Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardio 1999; 33: 1317–1322.

    Article  CAS  Google Scholar 

  44. Dressler FA, Craig WR, Castello R, Labovitz AJ. Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol 1998; 31: 134–138.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Jay D. Coffman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, Boston University Medical Center, Boston, MA, USA

    Jay D. Coffman MD  & Robert T. Eberhardt MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Coffman, J.D. (2003). Atheromatous Embolism. In: Coffman, J.D., Eberhardt, R.T. (eds) Peripheral Arterial Disease. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-331-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-331-6_17

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-326-8

  • Online ISBN: 978-1-59259-331-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation